<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00393510</url>
  </required_header>
  <id_info>
    <org_study_id>CRE-8342</org_study_id>
    <nct_id>NCT00393510</nct_id>
  </id_info>
  <brief_title>Herbal Preparation Used as Adjuvant Therapy on Diabetic Ulcers</brief_title>
  <official_title>An Evidence Base Study on the Clinical Effects of Integrated Western Medicine and Traditional Chinese Medicine for Diabetic Foot Ulcer Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic foot ulcers occurring among diabetic patients are difficult to heal. The frequent
      elderly age with co-morbidities, vascular insufficiencies, peripheral neuropathies and super
      imposed infections, all contribute towards the chronicity and failure of treatment.
      Preserving the ulcerated limb is the patients' wish. On the other hand, an infected ulcer
      that never heals just unnecessarily prolongs suffering. Nevertheless, patients earnestly like
      to try all methods of healing before accepting amputation.

      Objective:To determine whether a course of herbal preparation used as an adjuvant therapy for
      diabetic patients suffering from chronic foot ulcers may promote healing so that major leg
      amputation can be avoided.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2000</start_date>
  <completion_date type="Actual">March 2006</completion_date>
  <primary_completion_date type="Actual">March 2006</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Limb Salvage</measure>
    <time_frame>24 weeks</time_frame>
    <description>The number of successful limb rescued (without amputation).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tumour Necrosis Factor-alpha Levels in Serum</measure>
    <time_frame>Baseline and 4 week</time_frame>
    <description>The state of inflammation at baseline and at 4 weeks after treatment. TNF-alpha are in value of serum level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of Ulcer Healing</measure>
    <time_frame>24 week</time_frame>
    <description>Time taken for maturation of granulation to enable skin grafting.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Diabetic Foot Ulcer</condition>
  <condition>Amputation</condition>
  <arm_group>
    <arm_group_label>Traditional Chinese Medicine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 herbals formulation was given as an adjuvant therapy for the patients orally twice a day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo was made with starch and colouring materials. Given to patient orally twice a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TCM</intervention_name>
    <description>The Decoction is taken orally, twice a day, treatment period is 24 weeks The herbal formulation or a placebo was given as an adjuvant therapy for the treatment of the unhealing ulcers in these diabetic patients.
The formula consisted of 12 herbs, viz:
Radix astragali, Rhizoma atractylodis marcocephalae, Radix stephaniae tetrandrae, Radix polygoni multiflori, Radix rehmanniae, Radix smilax china, Fructus corni, Rhizoma dioscoreae, Cortex moutan, Rhizoma alismatis, Rhizoma smilacis glabrae, and Fructus schisandrae</description>
    <arm_group_label>Traditional Chinese Medicine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo taking orally, twice a day, 24 week treatment period The herbal formulation or a placebo was given as an adjuvant therapy for the treatment of the unhealing ulcers in these diabetic patients.
The placebo was made with starch and colouring materials.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Well Controlled diabetic state

          -  Presence of gangrene or non-healing ulcer in diabetic patients over the foot or feet.
             Infection should be well controlled.

          -  Good glycaemic control

        Exclusion Criteria:

          -  Pregnant women and women at risk of conception

          -  Patients taking digitalis glycosides

          -  Patients with abnormal liver function tests

          -  Patients with plasma creatinine great then 150 umol/l or unstable renal function

          -  Poorly controlled Diabetes Mellitus

          -  Uncontrolled infection

          -  History of adverse reaction to herbal medicine

          -  Unstable medical conditions

          -  Non-compliance with regime
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leung Ping Chung, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Orthopaedics &amp; Traumatology, CUHK</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Orthopaedics &amp; Traumatology, Prince of Wales hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Orthopaedics and Traumatology, Kwong Wah Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Levin ME. Diabetic foot ulcers: pathogenesis and management. J ET Nurs. 1993 Sep-Oct;20(5):191-8.</citation>
    <PMID>8110884</PMID>
  </reference>
  <reference>
    <citation>Nelz√©n O, Bergqvist D, Lindhagen A. High prevalence of diabetes in chronic leg ulcer patients: a cross-sectional population study. Diabet Med. 1993 May;10(4):345-50.</citation>
    <PMID>8508618</PMID>
  </reference>
  <reference>
    <citation>Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care. 1992 Nov;15(11):1598-604.</citation>
    <PMID>1468291</PMID>
  </reference>
  <reference>
    <citation>Ahlgren SC, Levine JD. Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J Neurophysiol. 1994 Aug;72(2):684-92.</citation>
    <PMID>7983528</PMID>
  </reference>
  <reference>
    <citation>Bazan NG, Gordon WC, Marcheselli VL, Lukiw WJ, Duhault J, Koenig-Berard E, Linn DM, DeCoster MA, Mukherjee PK. Experimental models and their use in studies of diabetic retinal microangiopathy. Therapie. 1997 Sep-Oct;52(5):447-51.</citation>
    <PMID>9501573</PMID>
  </reference>
  <reference>
    <citation>Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR. Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Brain Res Mol Brain Res. 1994 Jan;21(1-2):171-5.</citation>
    <PMID>7513041</PMID>
  </reference>
  <reference>
    <citation>Follansbee MH, Beyer KH Jr, Griffith JW, Vesell ES. Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats. Pharmacology. 1997 May;54(5):241-55.</citation>
    <PMID>9380770</PMID>
  </reference>
  <reference>
    <citation>Kunjathoor VV, Wilson DL, LeBoeuf RC. Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest. 1996 Apr 1;97(7):1767-73.</citation>
    <PMID>8601643</PMID>
  </reference>
  <reference>
    <citation>Liu S, Barac-Nieto M. Renal protein degradation in streptozotocin diabetic mice. Diabetes Res Clin Pract. 1997 Jan;34(3):143-8.</citation>
    <PMID>9069565</PMID>
  </reference>
  <reference>
    <citation>Mavrikakis ME, Sfikakis PP, Kontoyannis D, Horti M, Kittas C, Koutras DA, Raptis SA. Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative study. Exp Clin Endocrinol Diabetes. 1998;106(1):35-40.</citation>
    <PMID>9516057</PMID>
  </reference>
  <reference>
    <citation>Zochodne DW, Murray MM, van der Sloot P, Riopelle RJ. Distal tibial mononeuropathy in diabetic and nondiabetic rats reared on wire cages: an experimental entrapment neuropathy. Brain Res. 1995 Nov 6;698(1-2):130-6.</citation>
    <PMID>8581471</PMID>
  </reference>
  <reference>
    <citation>Wagner EW. Classification of neuropathic foot problems AAOS instructional lecture 28 St. Louis Mosby 1979 p143-165</citation>
  </reference>
  <reference>
    <citation>Brodsky JW. Diabetic Foot Surgery of Foot and Ankle. St. louis Mosby 1992, p1361-1467</citation>
  </reference>
  <reference>
    <citation>Conn, H.M., M.A. and Emmel, V.M. Staining Procedures. Williams and Wilkins Co., Baltimore, 289 pp.m (1960)</citation>
  </reference>
  <reference>
    <citation>Professor P.C. Leung. Limb Salvage for Diabetic ulceration with Traditional Chinese Techniques. Pacific, BioTech News. Vol.1 No.31 1998, Singapore</citation>
  </reference>
  <reference>
    <citation>J.Y.Shi, Collected publications on the applicatioin of Shi's regime for the treatment of diabetic ulcers (in Chinese) special publicaiton on Diabetic Ulcer. Shanghai Research Institute on TCM.</citation>
  </reference>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2006</study_first_submitted>
  <study_first_submitted_qc>October 26, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2006</study_first_posted>
  <results_first_submitted>November 23, 2009</results_first_submitted>
  <results_first_submitted_qc>June 2, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 1, 2010</results_first_posted>
  <last_update_submitted>July 6, 2010</last_update_submitted>
  <last_update_submitted_qc>July 6, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>The Institute of Chinese Medicine, CUHK</name_title>
    <organization>The Institute of Chinese Medicine, CUHK</organization>
  </responsible_party>
  <keyword>Diabetic Foot Ulcer</keyword>
  <keyword>Traditional Chinese Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Apr 2002 to Apr 2006, Orthopaedic Department, Prince of Wales Hospital, HK Apr 2002 to Apr 2006, Orthopaedic Department, Kwong Wah Hospital, HK</recruitment_details>
      <pre_assignment_details>Liver Function and Renal Function test normal. Patients suffering from serious cardiac and renal deficiencies were excluded from the study because of safety measure.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Traditional Chinese Medicine</title>
          <description>12 herbals formulation was given as an adjuvant therapy for the patients orally twice a day.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo was made with starch and colouring materials. Given to patient orally twice a day</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Traditional Chinese Medicine</title>
          <description>12 herbals formulation was given as an adjuvant therapy for the patients orally twice a day.</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo was made with starch and colouring materials. Given to patient orally twice a day</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.3" spread="12.6"/>
                    <measurement group_id="B2" value="68.5" spread="11.1"/>
                    <measurement group_id="B3" value="67.4" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hong Kong</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Limb Salvage</title>
        <description>The number of successful limb rescued (without amputation).</description>
        <time_frame>24 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Traditional Chinese Medicine</title>
            <description>12 herbals formulation was given as an adjuvant therapy for the patients orally twice a day.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo was made with starch and colouring materials. Given to patient orally twice a day</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Limb Salvage</title>
          <description>The number of successful limb rescued (without amputation).</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tumour Necrosis Factor-alpha Levels in Serum</title>
        <description>The state of inflammation at baseline and at 4 weeks after treatment. TNF-alpha are in value of serum level.</description>
        <time_frame>Baseline and 4 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Traditional Chinese Medicine</title>
            <description>12 herbals formulation was given as an adjuvant therapy for the patients orally twice a day.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo was made with starch and colouring materials. Given to patient orally twice a day</description>
          </group>
        </group_list>
        <measure>
          <title>Tumour Necrosis Factor-alpha Levels in Serum</title>
          <description>The state of inflammation at baseline and at 4 weeks after treatment. TNF-alpha are in value of serum level.</description>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" spread="116"/>
                    <measurement group_id="O2" value="44" spread="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" spread="62"/>
                    <measurement group_id="O2" value="39" spread="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time of Ulcer Healing</title>
        <description>Time taken for maturation of granulation to enable skin grafting.</description>
        <time_frame>24 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Traditional Chinese Medicine</title>
            <description>12 herbals formulation was given as an adjuvant therapy for the patients orally twice a day.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo was made with starch and colouring materials. Given to patient orally twice a day</description>
          </group>
        </group_list>
        <measure>
          <title>Time of Ulcer Healing</title>
          <description>Time taken for maturation of granulation to enable skin grafting.</description>
          <units>Weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="1.4"/>
                    <measurement group_id="O2" value="9.2" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24weeks</time_frame>
      <desc>During the 24 weeks of treatment, some selflimiting adverse events (epigastric pain, dry month,and diarrhoea) were experienced.</desc>
      <group_list>
        <group group_id="E1">
          <title>Traditional Chinese Medicine</title>
          <description>12 herbals formulation was given as an adjuvant therapy for the patients orally twice a day.</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo was made with starch and colouring materials. Given to patient orally twice a day</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Leung Ping Chung</name_or_title>
      <organization>Institute of Chinese Medicine, Chinese University of Hong Kong</organization>
      <phone>(852)2252 8863</phone>
      <email>pingcleung@cuhk.edu.hk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

